标题
Effects of the IL-23–IL-17 pathway on bone in spondyloarthritis
作者
关键词
-
出版物
Nature Reviews Rheumatology
Volume -, Issue -, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-09-29
DOI
10.1038/s41584-018-0091-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The role of IL-23 receptor signaling in inflammation-mediated erosive autoimmune arthritis and bone remodeling
- (2018) Wida Razawy et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The positive effects of secreting cytokines IL-17 and IFN-γ on the early-stage differentiation and negative effects on the calcification of primary osteoblasts in vitro
- (2018) Zhongxiu Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
- (2018) Marie-Astrid Boutet et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study
- (2018) Elizabeth G. Araujo et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Lights and shadows of NSAIDs in bone healing: the role of prostaglandins in bone metabolism
- (2018) Barbara Lisowska et al. Drug Design Development and Therapy
- Augmented Th17 Differentiation Leads to Cutaneous and Synovio-Entheseal Inflammation in a Novel Model of Psoriatic Arthritis
- (2018) Lu Yang et al. Arthritis & Rheumatology
- Whodunit? The Contribution of Interleukin (IL)-17/IL-22-Producing γδ T Cells, αβ T Cells, and Innate Lymphoid Cells to the Pathogenesis of Spondyloarthritis
- (2018) Annika Reinhardt et al. Frontiers in Immunology
- Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
- (2018) Dominique Baeten et al. ANNALS OF THE RHEUMATIC DISEASES
- Pathogenesis of ankylosing spondylitis — recent advances and future directions
- (2017) Vidya Ranganathan et al. Nature Reviews Rheumatology
- Brief Report: Group 3 Innate Lymphoid Cells in Human Enthesis
- (2017) Richard J. Cuthbert et al. Arthritis & Rheumatology
- Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study
- (2016) Jürgen Braun et al. ANNALS OF THE RHEUMATIC DISEASES
- Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1
- (2016) Philip J Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis
- (2016) Jacek Karczewski et al. AUTOIMMUNITY
- Proinflammatory T cells and IL-17 stimulate osteoblast differentiation
- (2016) Michiel Croes et al. BONE
- The roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity
- (2016) Xinyang Song et al. Cellular & Molecular Immunology
- Presence of HLA-B27 is associated with changes of serum levels of mediators of the Wnt and hedgehog pathway
- (2016) Sarah Aschermann et al. JOINT BONE SPINE
- Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease
- (2016) René Pfeifle et al. NATURE IMMUNOLOGY
- Chronic skin inflammation leads to bone loss by IL-17–mediated inhibition of Wnt signaling in osteoblasts
- (2016) Özge Uluçkan et al. Science Translational Medicine
- Brief Report: Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis
- (2016) Désirée van der Heijde et al. Arthritis & Rheumatology
- Th17 Cytokines Regulate Osteoclastogenesis in Rheumatoid Arthritis
- (2015) Kyoung-Woon Kim et al. AMERICAN JOURNAL OF PATHOLOGY
- Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose–response study of AMG 162 (Denosumab) in patients withRheumatoId arthritis on methotrexate toValidate inhibitory effect on boneErosion (DRIVE)—a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial
- (2015) Tsutomu Takeuchi et al. ANNALS OF THE RHEUMATIC DISEASES
- Analysis of periarticular bone changes in patients with cutaneous psoriasis without associated psoriatic arthritis
- (2015) David Simon et al. ANNALS OF THE RHEUMATIC DISEASES
- RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation
- (2015) Lynett Danks et al. ANNALS OF THE RHEUMATIC DISEASES
- Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice
- (2015) Elisa Montaldo et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Quantitative and Qualitative Changes of Bone in Psoriasis and Psoriatic Arthritis Patients
- (2015) Roland Kocijan et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
- (2015) Dominique Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
- (2015) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss
- (2015) Ulrike Harre et al. Nature Communications
- Integrated Genomics Identifies Convergence of Ankylosing Spondylitis with Global Immune Mediated Disease Pathways
- (2015) Mohammed Uddin et al. Scientific Reports
- Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
- (2014) Christopher Ritchlin et al. ANNALS OF THE RHEUMATIC DISEASES
- Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)
- (2014) Denis Poddubnyy et al. ANNALS OF THE RHEUMATIC DISEASES
- Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials
- (2014) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-17 inhibits osteoblast differentiation and bone regeneration in rat
- (2014) Yong-Gun Kim et al. ARCHIVES OF ORAL BIOLOGY
- Interleukin-17 is a critical target for the treatment of ankylosing enthesitis and psoriasis-like dermatitis in mice
- (2014) Shin Ebihara et al. AUTOIMMUNITY
- Cellular sources of IL-17 in psoriasis: a paradigm shift?
- (2014) Romy R. M. C. Keijsers et al. EXPERIMENTAL DERMATOLOGY
- IL-23 Inhibits Osteoclastogenesis Indirectly through Lymphocytes and Is Required for the Maintenance of Bone Mass in Mice
- (2014) J. M. W. Quinn et al. JOURNAL OF IMMUNOLOGY
- IL-23 Induces Receptor Activator of NF- B Ligand Expression on CD4+ T Cells and Promotes Osteoclastogenesis in an Autoimmune Arthritis Model
- (2014) J. H. Ju et al. JOURNAL OF IMMUNOLOGY
- Crosstalk among IL-23 and DNAX Activating Protein of 12 kDa–Dependent Pathways Promotes Osteoclastogenesis
- (2014) Hyun-Seock Shin et al. JOURNAL OF IMMUNOLOGY
- Ankylosing enthesitis associated with up-regulated IFN-γ and IL-17 production in (BXSB × NZB) F1 male mice: a new mouse model
- (2014) Yasuharu Abe et al. Modern Rheumatology
- Genetic and epigenetic fine mapping of causal autoimmune disease variants
- (2014) Kyle Kai-How Farh et al. NATURE
- Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies
- (2013) Arnd Kleyer et al. ANNALS OF THE RHEUMATIC DISEASES
- The role of interleukin-17 in bone metabolism and inflammatory skeletal diseases
- (2013) Youngkyun Lee BMB Reports
- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
- (2013) Iain B McInnes et al. LANCET
- Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
- (2013) Dominique Baeten et al. LANCET
- Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1
- (2013) Chuan Wu et al. NATURE
- Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis
- (2013) Noriko Komatsu et al. NATURE MEDICINE
- Relationship between inflammation, bone destruction, and osteoproliferation in the HLA-B27/human β2-microglobulin-transgenic rat model of spondylarthritis
- (2012) Leonie M. van Duivenvoorde et al. ARTHRITIS AND RHEUMATISM
- Expression of HLA-B27 causes loss of migratory dendritic cells in a rat model of spondylarthritis
- (2012) Lotta Utriainen et al. ARTHRITIS AND RHEUMATISM
- IL-17 mediates estrogen-deficient osteoporosis in an Act1-dependent manner
- (2012) Carl J. DeSelm et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
- (2012) Ulrike Harre et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells
- (2012) Jonathan P Sherlock et al. NATURE MEDICINE
- Interleukin-17A upregulates receptor activator of NF-κB on osteoclast precursors
- (2012) Iannis E Adamopoulos et al. ARTHRITIS RESEARCH & THERAPY
- Functional role of IL-22 in psoriatic arthritis
- (2012) Anupam Mitra et al. ARTHRITIS RESEARCH & THERAPY
- Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features
- (2012) Raquel Celis et al. ARTHRITIS RESEARCH & THERAPY
- Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis
- (2011) Tony J. Kenna et al. ARTHRITIS AND RHEUMATISM
- Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts
- (2011) Kyoung-Woon Kim et al. ARTHRITIS AND RHEUMATISM
- Interleukin-33, a Target of Parathyroid Hormone and Oncostatin M, Increases Osteoblastic Matrix Mineral Deposition and Inhibits Osteoclast Formationin Vitro
- (2011) Hasnawati Saleh et al. ENDOCRINOLOGY
- Th17 Cells, Not IL-17+ T Cells, Drive Arthritic Bone Destruction in Mice and Humans
- (2011) B. Pollinger et al. JOURNAL OF IMMUNOLOGY
- IL-23 Is Critical for Induction of Arthritis, Osteoclast Formation, and Maintenance of Bone Mass
- (2011) I. E. Adamopoulos et al. JOURNAL OF IMMUNOLOGY
- The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans
- (2011) Paola Di Meglio et al. PLoS One
- Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses
- (2011) R. Sarin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response
- (2011) Heiner Appel et al. ARTHRITIS RESEARCH & THERAPY
- Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis
- (2010) Yang Mei et al. CLINICAL RHEUMATOLOGY
- Generation of pathogenic TH17 cells in the absence of TGF-β signalling
- (2010) Kamran Ghoreschi et al. NATURE
- Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis
- (2009) Hui Shen et al. ARTHRITIS AND RHEUMATISM
- Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis
- (2009) Heiner Appel et al. ARTHRITIS AND RHEUMATISM
- IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling
- (2009) H Huang et al. CELL DEATH AND DIFFERENTIATION
- A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss
- (2009) Jaya Goswami et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IL-23 induces receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-κB signal pathways
- (2009) Xia Li et al. IMMUNOLOGY LETTERS
- Osteoblast Function Is Compromised at Sites of Focal Bone Erosion in Inflammatory Arthritis
- (2009) Nicole C Walsh et al. JOURNAL OF BONE AND MINERAL RESEARCH
- IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-α antibody: A novel mechanism of osteoclastogenesis by IL-17
- (2009) Toru Yago et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine
- (2008) R Landewe et al. ANNALS OF THE RHEUMATIC DISEASES
- Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial
- (2008) Stanley B. Cohen et al. ARTHRITIS AND RHEUMATISM
- Review: Immune cells and mediators of inflammatory arthritis
- (2008) Georg Schett AUTOIMMUNITY
- IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-κB (RANK) expression in myeloid precursor cells
- (2008) Li Chen et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Genetic Variants of the IL-23R Pathway: Association with Psoriatic Arthritis and Psoriasis Vulgaris, but No Specific Risk Factor for Arthritis
- (2008) Ulrike Hüffmeier et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started